Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Emergent Biosolutions Inc

+ Add to Watchlist

ER4:GR

27.845 EUR 0.013 0.05%

As of 02:08:39 ET on 05/25/2015.

Snapshot for Emergent Biosolutions Inc (ER4)

Open: 27.845 Day's Range: 27.845 - 27.845 Volume: 0
Previous Close: 27.858 52wk Range: 15.223 - 28.601 1-Yr Rtn: +81.52%

Stock Chart for ER4

No chart data available.
  • ER4:GR 27.845
  • 1M
  • 1Y
27.858
Interactive ER4 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ER4

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 22.6576
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) 1.3500
Est. PEG Ratio -
Market Cap (M EUR) 1,068.04
Shares Outstanding (M) 38.36
30 Day Average Volume 331
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ER4

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ER4

Emergent Biosolutions, Inc. develops and produces immunobiotics, pharmaceutical products that assist the body's immune system to prevent or treat disease. The Company produces a vaccine for anthrax.

Fuad El-HibriChairmanDaniel J Abdun-NabiPresident/CEO
Adam HaveyExec VP/President:BiodefenseBarry A LabingerExec VP/Pres:Biosciences
More Company Profile & Key Executives for ER4

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil